We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
5826
Seres Therapeutics
MCRB
$48.9M
$139K ﹤0.01%
2,018
+913
+83% +$67.7K
RCA
5827
DELISTED
Ready Capital Corporation 7.00% Convertible Senior Notes due 2023
RCA
$139K ﹤0.01%
5,178
+2,078
+67% +$56.3K
BNED icon
5828
Barnes & Noble Education
BNED
$443M
$138K ﹤0.01%
324
+305
+1,605% +$125K
EWK icon
5829
iShares MSCI Belgium ETF
EWK
$165M
$138K ﹤0.01%
6,892
PRGX
5830
DELISTED
PRGX Global, Inc.
PRGX
$138K ﹤0.01%
28,137
+10,431
+59% +$50.6K
TSLF
5831
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$138K ﹤0.01%
9,072
+3,853
+74% +$56.4K
RIV
5832
RiverNorth Opportunities Fund
RIV
$317M
$137K ﹤0.01%
8,372
-16,288
-66% -$266K
SPRO icon
5833
Spero Therapeutics
SPRO
$73M
$137K ﹤0.01%
14,267
+3,216
+29% +$34.7K
ELVT
5834
DELISTED
Elevate Credit, Inc.
ELVT
$137K ﹤0.01%
30,804
+6,522
+27% +$27.2K
CHK
5835
DELISTED
Chesapeake Energy Corporation
CHK
$137K ﹤0.01%
829
+499
+151% +$100K
ACNT icon
5836
Ascent Industries
ACNT
$141M
$136K ﹤0.01%
10,543
+3,110
+42% +$43.2K
EEMS icon
5837
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$373M
$136K ﹤0.01%
3,013
+24
+0.8% +$1.04K
NGVC icon
5838
Vitamin Cottage Natural Grocers
NGVC
$654M
$136K ﹤0.01%
13,773
+6,169
+81% +$56.6K
SAMG icon
5839
Silvercrest Asset Management
SAMG
$79.9M
$136K ﹤0.01%
10,777
+3,317
+44% +$41.8K
CSF
5840
DELISTED
VictoryShares US Discovery Enhanced Volatility Wtd ETF
CSF
$136K ﹤0.01%
3,423
+1,885
+123% +$71.8K
EXD
5841
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
$136K ﹤0.01%
13,237
-504
-4% -$4.99K
ABEO icon
5842
Abeona Therapeutics
ABEO
$413M
$135K ﹤0.01%
1,656
+636
+62% +$44.9K
ASPS icon
5843
Altisource Portfolio Solutions
ASPS
$65.8M
$135K ﹤0.01%
877
+230
+36% +$35.2K
CLIX icon
5844
ProShares Long Online/Short Stores ETF
CLIX
$6.36M
$135K ﹤0.01%
2,756
+1,377
+100% +$66K
DEO icon
5845
PUT
Diageo
DEO
$53.6B
$135K ﹤0.01%
800
-300
-27% -$48.8K
EYPT icon
5846
EyePoint Inc
EYPT
$1.2B
$135K ﹤0.01%
8,722
+5,064
+138% +$90.3K
ICMB icon
5847
Investcorp Credit Management BDC
ICMB
$12.1M
$135K ﹤0.01%
20,237
-112,530
-85% -$763K
LVL
5848
DELISTED
Invesco S&P Global Dividend Opportunities Index ETF
LVL
$135K ﹤0.01%
11,093
+2,744
+33% +$32.9K
INDL icon
5849
Direxion Daily MSCI India Bull 2X ETF
INDL
$58.2M
$134K ﹤0.01%
+1,957
New +$126K
ARKK icon
5850
ARK Innovation ETF
ARKK
$6.29B
$133K ﹤0.01%
2,645
-305
-10% -$14.2K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.